Canada markets close in 2 hours

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.44-0.07 (-0.38%)
As of 02:00PM EDT. Market open.
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-06-30
Assets
Current Assets
Cash
Cash And Cash Equivalents
132,100
56,900
257,400
163,700
Other Short Term Investments
8,800
58,000
81,400
54,100
Total Cash
140,900
114,900
338,800
217,800
Net Receivables
114,300
101,600
91,300
68,100
Inventory
22,000
20,100
15,300
29,100
Other Current Assets
19,400
20,400
21,000
-
Total Current Assets
313,600
274,600
484,800
331,700
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
300,500
296,500
232,200
209,900
Accumulated Depreciation
-119,900
-109,200
-106,900
-106,900
Net property, plant and equipment
180,600
187,300
125,300
103,000
Equity and other investments
0
54,800
59,000
37,000
Goodwill
287,400
286,800
239,200
327,600
Intangible Assets
349,500
379,700
404,100
605,300
Other long-term assets
15,400
15,500
8,300
-
Total non-current assets
832,900
924,100
835,900
1,072,900
Total Assets
1,146,500
1,198,700
1,320,700
1,404,600
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
25,800
28,800
29,600
21,700
Accrued liabilities
29,100
29,000
89,900
17,200
Deferred revenues
-
600
5,200
32,800
Other Current Liabilities
10,400
-
-
3,100
Total Current Liabilities
155,900
137,200
204,300
147,000
Non-current liabilities
Long Term Debt
38,500
-
-
224,400
Deferred taxes liabilities
-
3,500
35,800
26,600
Other long-term liabilities
41,300
18,000
5,600
8,000
Total non-current liabilities
207,400
175,700
148,600
339,400
Total Liabilities
363,300
312,900
352,900
486,400
Stockholders' Equity
Common Stock
900
800
800
700
Retained Earnings
-629,500
-366,200
-254,200
-173,900
Accumulated other comprehensive income
-3,700
-8,900
-5,100
-5,200
Total stockholders' equity
783,200
885,800
967,800
918,200
Total liabilities and stockholders' equity
1,146,500
1,198,700
1,320,700
1,404,600